|
Sign In to gain access to subscriptions and/or personal tools.
|
Journal of Geriatric Psychiatry and Neurology, Vol. 13, No. 1,
43-48 (2000)
DOI: 10.1177/089198870001300107
Fluvoxamine Pharmacotherapy of Anxiety Disorders in Later Life: Preliminary Open-Trial Data
Mary E. Wylie, MD
Mark D. Miller, MD
M. Katherine Shear, MD
John T. Little, MD
Benoit H. Mulsant, MD
Bruce G. Pollock, MD, PhD
Charles F. Reynolds, MD
The authors present data from an open trial of fluvoxamine (median daily dosage: 200 mg) in the treatment of generalized anxiety disorder, panic disorder, and obsessive-compulsive disorder in 19 older outpatients (mean age = 66.8). Of the 12 subjects completing the 21-week trial, 8 achieved a good response (50% reduction in symptom measures) and 7 were rated as much or very much improved. Fluvoxamine pharmacotherapy also had a significant effect in reducing comorbid depressive symptoms and in increasing levels of functioning. These data support the effectiveness of fluvoxamine in older subjects with anxiety disorders (particularly generalized anxiety disorder) and warrant further double-blind, placebo-controlled evaluation. (J Geriatr Psychiatry Neurol 2000; 13:4348).

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Pinquart and P. R. Duberstein
Treatment of Anxiety Disorders in Older Adults: A Meta-analytic Comparison of Behavioral and Pharmacological Interventions
Am J Geriatr Psychiatry,
August 1, 2007;
15(8):
639 - 651.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
References
PsychiatryOnline CME,
May 1, 2007;
2007(1):
2 - 2.
[Full Text]
|
 |
|

|
 |

|
 |
 
E. J. Lenze, B. H. Mulsant, J. Mohlman, M. K. Shear, M. A. Dew, R. Schulz, M. D. Miller, B. Tracey, and C. F. Reynolds III
Generalized Anxiety Disorder in Late Life: Lifetime Course and Comorbidity With Major Depressive Disorder
Am J Geriatr Psychiatry,
January 1, 2005;
13(1):
77 - 80.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Lenze, B. H. Mulsant, M. K. Shear, M. A. Dew, M. D. Miller, B. G. Pollock, P. Houck, B. Tracey, and C. F. Reynolds III
Efficacy and Tolerability of Citalopram in the Treatment of Late-Life Anxiety Disorders: Results From an 8-Week Randomized, Placebo-Controlled Trial
Am J Psychiatry,
January 1, 2005;
162(1):
146 - 150.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|